Insomnia therapy has promising economic evidence, with gaps for other sleep conditions
A review of economic evaluations favored cognitive behavioural therapy for insomnia, while evidence for adolescents and hypersomnia was sparse or absent.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Cognitive behavioural therapy for insomnia had the strongest economic evidence in this review. Both that therapy and medication were judged likely to offer value compared with inactive controls. Digital therapy was reported to save costs in some comparisons, but the abstract does not show how much or in which settings.
This abstract-based account cannot identify the countries, evaluation time horizons or uncertainty behind the economic conclusions. No eligible hypersomnia evaluations were found, and evidence for adolescent insomnia was limited.
What researchers found
Healthcare and societal costs
Digital CBT-I versus in-person CBT-I or medication; evaluation time horizons and savings amounts were not reported in the abstract.
Costs and outcomes
An economic evaluation asks how treatment costs relate to its outcomes. The review's conclusion about cost-effectiveness should therefore be read as a value assessment, rather than a direct ranking of symptom improvement.
Where evidence was missing
Most included evaluations concerned adults or older adults with insomnia. Only 2 focused on adolescents, none assessed hypersomnia treatment, and the economic evidence for complementary or alternative approaches remained unclear.
The original publication
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia.
Le PH, Le LK, Le DQ et al.
Appl Health Econ Health Policy · 2026
- PubMed ID
- 40956569
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.